These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 25707004)

  • 21. Strategy to enhance transgene expression in proximity of amyloid plaques in a mouse model of Alzheimer's disease.
    Weber-Adrian D; Kofoed RH; Chan JWY; Silburt J; Noroozian Z; Kügler S; Hynynen K; Aubert I
    Theranostics; 2019; 9(26):8127-8137. PubMed ID: 31754385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E deposition and astrogliosis are associated with maturation of beta-amyloid plaques in betaAPPswe transgenic mouse: Implications for the pathogenesis of Alzheimer's disease.
    Terai K; Iwai A; Kawabata S; Sasamata M; Miyata K; Yamaguchi T
    Brain Res; 2001 May; 900(1):48-56. PubMed ID: 11325345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The difference in gliosis induced by β-amyloid and Tau treatments in astrocyte cultures derived from senescence accelerated and normal mouse strains.
    Lü L; Mak YT; Fang M; Yew DT
    Biogerontology; 2009 Dec; 10(6):695-710. PubMed ID: 19221889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population variation in glial fibrillary acidic protein levels in brain ageing: relationship to Alzheimer-type pathology and dementia.
    Wharton SB; O'Callaghan JP; Savva GM; Nicoll JA; Matthews F; Simpson JE; Forster G; Shaw PJ; Brayne C; Ince PG;
    Dement Geriatr Cogn Disord; 2009; 27(5):465-73. PubMed ID: 19420941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Astrocytes deficient in circadian clock gene Bmal1 show enhanced activation responses to amyloid-beta pathology without changing plaque burden.
    McKee CA; Lee J; Cai Y; Saito T; Saido T; Musiek ES
    Sci Rep; 2022 Feb; 12(1):1796. PubMed ID: 35110643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CaV1.2 calcium channel expression in reactive astrocytes is associated with the formation of amyloid-β plaques in an Alzheimer's disease mouse model.
    Daschil N; Obermair GJ; Flucher BE; Stefanova N; Hutter-Paier B; Windisch M; Humpel C; Marksteiner J
    J Alzheimers Dis; 2013; 37(2):439-51. PubMed ID: 23948887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffuse Amyloid-β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques.
    Abner EL; Neltner JH; Jicha GA; Patel E; Anderson SL; Wilcock DM; Van Eldik LJ; Nelson PT
    J Alzheimers Dis; 2018; 64(4):1307-1324. PubMed ID: 30040735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid-β dimers in the absence of plaque pathology impair learning and synaptic plasticity.
    Müller-Schiffmann A; Herring A; Abdel-Hafiz L; Chepkova AN; Schäble S; Wedel D; Horn AH; Sticht H; de Souza Silva MA; Gottmann K; Sergeeva OA; Huston JP; Keyvani K; Korth C
    Brain; 2016 Feb; 139(Pt 2):509-25. PubMed ID: 26657517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of regional amyloid-β plaque and phospho-tau pathology with biological factors and neuropsychological functioning among HIV-infected adults.
    Soontornniyomkij V; Moore DJ; Gouaux B; Soontornniyomkij B; Sinsheimer JS; Levine AJ
    J Neurovirol; 2019 Dec; 25(6):741-753. PubMed ID: 31144289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D Reduces GABA-Positive Astrocytes in the 5xFAD Mouse Model of Alzheimer's Disease.
    Kang J; Park M; Kim T
    J Alzheimers Dis; 2024; 97(4):1939-1950. PubMed ID: 38339931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-related plaque morphology and C-terminal heterogeneity of amyloid beta in Dutch-type hereditary cerebral hemorrhage with amyloidosis.
    Maat-Schieman ML; Yamaguchi H; van Duinen SG; Natté R; Roos RA
    Acta Neuropathol; 2000 Apr; 99(4):409-19. PubMed ID: 10787040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations of cortical astrogliosis with cognitive performance and dementia status.
    Kashon ML; Ross GW; O'Callaghan JP; Miller DB; Petrovitch H; Burchfiel CM; Sharp DS; Markesbery WR; Davis DG; Hardman J; Nelson J; White LR
    J Alzheimers Dis; 2004 Dec; 6(6):595-604; discussion 673-81. PubMed ID: 15665400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease.
    Kamphuis W; Middeldorp J; Kooijman L; Sluijs JA; Kooi EJ; Moeton M; Freriks M; Mizee MR; Hol EM
    Neurobiol Aging; 2014 Mar; 35(3):492-510. PubMed ID: 24269023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Label-free vibrational imaging of different Aβ plaque types in Alzheimer's disease reveals sequential events in plaque development.
    Röhr D; Boon BDC; Schuler M; Kremer K; Hoozemans JJM; Bouwman FH; El-Mashtoly SF; Nabers A; Großerueschkamp F; Rozemuller AJM; Gerwert K
    Acta Neuropathol Commun; 2020 Dec; 8(1):222. PubMed ID: 33308303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hippocampal GFAP-positive astrocyte responses to amyloid and tau pathologies.
    De Bastiani MA; Bellaver B; Brum WS; Souza DG; Ferreira PCL; Rocha AS; Povala G; Ferrari-Souza JP; Benedet AL; Ashton NJ; Karikari TK; Zetterberg H; Blennow K; Rosa-Neto P; Pascoal TA; Zimmer ER;
    Brain Behav Immun; 2023 May; 110():175-184. PubMed ID: 36878332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice.
    Wegiel J; Wang KC; Imaki H; Rubenstein R; Wronska A; Osuchowski M; Lipinski WJ; Walker LC; LeVine H
    Neurobiol Aging; 2001; 22(1):49-61. PubMed ID: 11164276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloid-β plaques may be reduced in advanced stages of cerebral amyloid angiopathy in the elderly.
    Okamoto K; Amari M; Fukuda T; Suzuki K; Takatama M
    Neuropathology; 2020 Oct; 40(5):474-481. PubMed ID: 32557936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease.
    Dickson TC; Vickers JC
    Neuroscience; 2001; 105(1):99-107. PubMed ID: 11483304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
    Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low amyloid (Abeta) plaque load and relative predominance of diffuse plaques distinguish argyrophilic grain disease from Alzheimer's disease.
    Tolnay M; Calhoun M; Pham HC; Egensperger R; Probst A
    Neuropathol Appl Neurobiol; 1999 Aug; 25(4):295-305. PubMed ID: 10476046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.